Literature DB >> 15571964

Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma.

A Faried1, M Sohda, M Nakajima, T Miyazaki, H Kato, H Kuwano.   

Abstract

Cellular stress response and apoptosis are two highly conserved mechanisms for maintaining homeostasis. Hsp60 and Hsp90 have been shown to play pro- and anti-apoptotic roles, respectively. Our present study examined whether there is a correlation between the expression of Hsp60 and Hsp90, clinical parameters, the apoptotic index (AI), and the prognosis of patients with oesophageal squamous cell carcinoma (ESCC). We immunohistochemically stained cells for Hsp60, Hsp90, and single-stranded DNA (ssDNA), which acts as an apoptotic marker. In normal oesophageal epithelium tissue, Hsp60 and Hsp90 were expressed in the cytoplasm and membrane from the basal cell layer to the supra-basal cell layers. Hsp60 and Hsp90 positive stainings (+) were found in 63 of 123 cases (51%) and 62 of 123 cases (50%), respectively. There was no correlation between Hsp60 and Hsp90 expression levels and any of the clinical parameters examined. The five-year survival rate for ESCC patients with Hsp60 (+) expression was significantly higher than for those patients with Hsp60 (-) expression (P=0.0371). Five-year survival rates of patients with Hsp60 (+) and (-) were 49% and 33%, respectively. By contrast, Hsp90 expression failed to predict patient prognosis (P=0.7965). The high-AI group did not have a significantly better prognosis than the low-AI group (P=0.2218). Statistical analysis showed a significant correlation between the expression of Hsp60 and AI in ESCC patients (P=0.008). Thus, the five-year survival rate for the high-AI/Hsp60 (+) group was statistically significantly better than for the other groups (P=0.0281). The results obtained in this study indicate that positive Hsp60 expression is a good prognostic indicator. This may be due to its role as a chaperone in contributing to the induction of apoptosis. These data suggest that Hsp60 expression correlates with the AI and patient prognosis in human ESCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571964     DOI: 10.1016/j.ejca.2004.08.013

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  HSP60 expression during carcinogenesis: a molecular "proteus" of carcinogenesis?

Authors:  Francesco Cappello; Giovanni Zummo
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

Review 2.  On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.

Authors:  Custer C Deocaris; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  Differences of onset age and survival rates in esophageal squamous cell carcinoma cases with and without family history of upper gastrointestinal cancer from a high-incidence area in North China.

Authors:  Denggui Wen; Shijie Wang; Liwei Zhang; Jianhui Zhang; Lizhen Wei; Xiuqing Zhao
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

4.  Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer.

Authors:  Shaoxiang Wang; Zhan Du; Jie Luo; Xiao Wang; Haiying Li; Yuting Liu; Yong Zhang; Jiwei Ma; Weiwei Xiao; Yifei Wang; Xueyun Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

5.  SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.

Authors:  Manoj Kumar Kashyap; H C Harsha; Santosh Renuse; Harsh Pawar; Nandini A Sahasrabuddhe; Min-Sik Kim; Arivusudar Marimuthu; Shivakumar Keerthikumar; Babylakshmi Muthusamy; Kumaran Kandasamy; Yashwanth Subbannayya; Thottethodi Subrahmanya Keshava Prasad; Riaz Mahmood; Raghothama Chaerkady; Stephen J Meltzer; Rekha V Kumar; Anil K Rustgi; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

6.  Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60.

Authors:  Renu Wadhwa; Syuichi Takano; Kamaljit Kaur; Satoshi Aida; Tomoko Yaguchi; Zeenia Kaul; Takashi Hirano; Kazunari Taira; Sunil C Kaul
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.

Authors:  Romy E Verbeek; Peter D Siersema; Fiebo J Ten Kate; Kees Fluiter; Rhonda F Souza; Frank P Vleggaar; Pauline Bus; Jantine W P M van Baal
Journal:  J Gastroenterol       Date:  2013-08-17       Impact factor: 7.527

8.  Cytosolic Hsp60 can modulate proteasome activity in yeast.

Authors:  Bella Kalderon; Gleb Kogan; Ettel Bubis; Ophry Pines
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

9.  Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.

Authors:  Hui-zhi Fan; Hang Liu; Chen Zhang; Dong-mei Gao; Qun Xue; Jun Chen; Rui-xia Sun; Yin-kun Liu; Peng-yuan Yang
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-14       Impact factor: 4.553

10.  HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma.

Authors:  Wenjing Ruan; Yinghong Wang; Yu Ma; Xiaoming Xing; Jie Lin; Jing Cui; Maode Lai
Journal:  J Exp Clin Cancer Res       Date:  2010-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.